Another bump for Boston biolab

Plans for a Biosafety Level 4 containment linkurl:lab;https://www.the-scientist.com/news/display/23468/ at Boston University hit another bump in the road yesterday (December 13), when the Massachusetts Supreme Judicial Court ruled unanimously that the state's environmental approval process for the project had been deeply flawed. The assessment echoed a recent National Research Council linkurl:review,;https://www.the-scientist.com/blog/display/53944/ which concluded last month that the NIH had al

By | December 14, 2007

Plans for a Biosafety Level 4 containment linkurl:lab;https://www.the-scientist.com/news/display/23468/ at Boston University hit another bump in the road yesterday (December 13), when the Massachusetts Supreme Judicial Court ruled unanimously that the state's environmental approval process for the project had been deeply flawed. The assessment echoed a recent National Research Council linkurl:review,;https://www.the-scientist.com/blog/display/53944/ which concluded last month that the NIH had also flubbed an environmental assessment of the project and did not adequately assess the safety risks. The ruling will not halt construction of the facility, which is 70% complete, the Boston Globe linkurl:reports;http://www.boston.com/news/local/articles/2007/12/14/ruling_may_stall_opening_of_biolab/ today. But it will require the university to complete another safety review in order to receive the needed permits for BSL4 work.

Popular Now

  1. How Gaining and Losing Weight Affects the Body
    Daily News How Gaining and Losing Weight Affects the Body

    Millions of measurements from 23 people who consumed extra calories every day for a month reveal changes in proteins, metabolites, and gut microbiota that accompany shifts in body mass.

  2. That Other CRISPR Patent Dispute
    Daily News That Other CRISPR Patent Dispute

    The Broad Institute and Rockefeller University disagree over which scientists should be named as inventors on certain patents involving the gene-editing technology.

  3. Neurons Use Virus-Like Proteins to Transmit Information
  4. EPO Revokes Broad’s CRISPR Patent
    The Nutshell EPO Revokes Broad’s CRISPR Patent

    Shortly after ruling out the earliest priority dates on a foundational patent for CRISPR gene-editing technology, the European Patent Office rescinded the patent entirely—and more are likely to follow.

AAAS